Skip to main content

unephra

Unephra develops a non-wearable system for continuous health monitoring using advanced urine analysis. This technology provides users with actionable, personalized physiological insights without intrusive methods. The platform leverages machine learning and micro-sensor arrays to measure key urine biomarkers for proactive health management.

Traction 2/10
San Francisco, United States · HQ
Founded 20234100+ followers
  • Artificial Intelligence
  • Data & Analytics
  • Biotechnology
  • Digital Health
  • Healthcare Technology
  • Software Only
Updated 29 days ago

Funding

Raised to date

$20KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

across 1 round

$20K · Undisclosed

Announced Oct 2025

Disclosed cumulative: $20K

Founders

1 founder

Farhad Taghibakhsh

Founder/CEO

Product

Problem

Cardiovascular patients, particularly those with heart failure or hypertension, require frequent monitoring of key health indicators like sodium levels and volume status to proactively manage their conditions. Traditional monitoring methods often rely on invasive procedures or inconvenient wearables, hindering continuous and seamless data collection.

Solution

Unephra offers a non-invasive, non-wearable solution for continuous health monitoring through advanced urine analysis. Their technology provides real-time, actionable insights into a patient's physiological state, enabling personalized health monitoring and care. By analyzing urine samples, Unephra's system delivers data-driven assessments of key biomarkers, empowering individuals and healthcare providers to proactively manage conditions like heart failure and hypertension. The system leverages a smart bio-sensing micro-sensor array for urine biomarker measurement, informed processing via advanced machine learning and statistical analysis, and an AI-assisted physiological human model for personalized insights.

Target Audience

The primary target audience includes cardiologists, general practitioners, and patients with cardiovascular conditions such as heart failure and hypertension, who require continuous and convenient health monitoring.

Features

  • Non-invasive urine analysis for continuous health monitoring
  • Smart bio-sensing using an adaptive micro-sensor array for urine biomarker measurement
  • AI-assisted physiological human model for personalized insights
  • Advanced machine learning and statistical analysis for informed processing of data
  • Real-time data access for proactive management of hypertension and heart failure
  • Non-wearable technology for a seamless user experience
This profile is AI-generated and may contain inaccuracies.